Explore Stanford technologies available for licensing:

Mitochondrial fragmentation and dysfunction is a key contributor to multiple clinical pathologies, including neurodegenerative disorders, sepsis, and myocardial infarction.

Stanford researchers have discovered using a novel assay that a large proportion of CRISPR/AAV modified cells contain hidden concatemeric knockins that affect gene expression, and therefore developed a strategy to reduce their occurrence.

Researchers within the Zare Lab, Department of Chemistry, have developed an eco-friendly, low cost, and simple method to produce inorganic small molecules (ammonia, hydrogen peroxide, oxygen, etc.) and short-chain organics (methanol, formic acid, ethane, etc.) through contact

Stanford researchers have created a new strategy for collecting and integrating human microbiome, multi-omics, and immune cell activation data that reveals new insights into the roles of different bacterial strains in human health.

Stanford researchers have developed an innovative technology for cryo-vitrification using a temperature-controlled cold gas stream instead of traditional liquid cryogen, which prevents grid distortion, enabling gentle sample cooling and continuous imaging throughout the vitrif

Stanford researchers have discovered BRP3, a novel peptide derived from the BRINP3 protein, which effectively reduces food intake and body fat in mice, while preserving muscle mass, thus offering a novel, safe and effective solution to treat obesity.

Researchers in Prof. Paul George's laboratory have patented a conductive polymer scaffold designed to electrically stimulate neural progenitor cells (NPCs) for enhanced neural regeneration.

Stanford scientists have developed cross-reactive antibodies that can bind human and murine NKp46 on NK cells and induce cytotoxicity and proliferation.

The skin cells that line the esophagus are critical for protecting against the friction of food when we swallow. However, they can be damaged by genetic disorders, caustic burns, and surgical resections for cancer treatment.

Type 1 regulatory T cells (Tr1s) are an inducible subtype of regulatory T cells that can play a beneficial (autoimmune diseases, allergy, hematological malignancies) or detrimental role (some solid tumors and infectious diseases) in human diseases. Tr1 cells.

Stanford researchers have developed a novel xeno-free, no purification, robust, quick, low-cost method for generating pure endothelial cell cultures by sequentially inducing mesodermal-lineage cells from pluripotent stem cells, using differentiation stage-specific extracellula

Researchers at Stanford have developed a novel deep-learning-based tool called CytoTRACE2 that interprets single-cell RNA sequencing (scRNA-seq) to enable the discovery of regenerative cells across all tissue types and novel targets in cancer and other diseases.

Early detection of ovarian cancer is crucial, with a 5-year survival rate exceeding 90%. Once this early window has been missed, the 5-year survival rate precipitously drops below 50%.

Stanford researchers have discovered the first of its kind gene therapy vector to treat eye diseases of the non-pigmented ciliary epithelium cells (NPCECs).

Stanford researchers in Dr. Mahajan's laboratory have discovered biomarkers to differentiate between infectious (endophthalmitis) and non-infectious uveitis; and, to accurately categorize the types of infectious uveitis.